- Revenue Cycle Management
- COVID-19
- Reimbursement
- Diabetes Awareness Month
- Risk Management
- Patient Retention
- Staffing
- Medical Economics® 100th Anniversary
- Coding and documentation
- Business of Endocrinology
- Telehealth
- Physicians Financial News
- Cybersecurity
- Cardiovascular Clinical Consult
- Locum Tenens, brought to you by LocumLife®
- Weight Management
- Business of Women's Health
- Practice Efficiency
- Finance and Wealth
- EHRs
- Remote Patient Monitoring
- Sponsored Webinars
- Medical Technology
- Billing and collections
- Acute Pain Management
- Exclusive Content
- Value-based Care
- Business of Pediatrics
- Concierge Medicine 2.0 by Castle Connolly Private Health Partners
- Practice Growth
- Concierge Medicine
- Business of Cardiology
- Implementing the Topcon Ocular Telehealth Platform
- Malpractice
- Influenza
- Sexual Health
- Chronic Conditions
- Technology
- Legal and Policy
- Money
- Opinion
- Vaccines
- Practice Management
- Patient Relations
- Careers
New drug for food allergies; teen alcohol abuse; ‘zombie cells’ – Morning Medical Update
The top news stories in medicine today.
© meeboonstudio - stock.adobe.com
The U.S. Food and Drug Administration has approved Xolair (omalizumab) for the reduction of allergic reactions to foods such as peanuts, milk, eggs, and cashews for patients aged 1 year and older. It is the first medication approved to reduce reactions in people with one or more food allergies. Genentech published this news release about it, and Pharmacy Times reports.
Preventing teen alcohol use and abuse
The National Institute of Health’s Institute on Alcohol Abuse and Alcoholism have joined with online quiz maker Kahoot to create new interactive and informative games for educators and learners. If you have adolescent patients, these may be some resources to direct them and parents – and learn more about these issues yourself.
What happens as people get older and “zombie cells” within the body release inflammatory and tissue-degrading molecules? Age-related health problems and diseases rooted at the cellular level, according to new studies published in Aging Cell and Nature. The Mayo Clinic’s research magazine Discovery’s Edge also has this summary.
